More on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the energy drink health concerns relatively "benign" and encouraging for shareholders of the company. The common sense approach by consumers is likely to be moderation and increased oversight by parents - instead of anything resembling a ban or graphic warning labels. MNST +12.5% to $51.50.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Mon, 1:13PM)
at Zacks.com (Mon, 8:44AM)
at Investor's Business Daily (Fri, 6:45PM)
at Benzinga.com (Fri, 10:02AM)
at Zacks.com (Fri, 9:06AM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs